Skip to main
XERS
XERS logo

Xeris Biopharma Holdings (XERS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy XERS Stock

About Xeris Biopharma Holdings (XERS)

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and relat...read more
Market cap$855.23M
Yesterday's volume4.69M
Revenue (TTM)$222.55M
Avg. daily volume2.23M
EBITDA (TTM)-$9.94M
Open$4.88
Price / earnings ratio-17.71x
Yesterday's range$4.82 - $5.36
Debt / equity
52 week range$2.1 - $6.07
5 year debt / equity-677.58x
Beta (LTM)1.21x
Interest coverage-1.01x
Dividend & yield$0.00 (0.00%)
Current ratio1.72x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

XERS Stock Rating

What analysts recommend for XERS stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 40%
Buy 50%
Hold 10%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 09, 2025, the market cap for XERS stock is $855.23M

The current P/E ratio for XERS stock is -17.71

The 52-week high for XERS stock is $6.07. The current XERS stock price $undefined is 100.00% below its 52-week high

The 52-week low for XERS stock is $2.10. The current XERS stock price $undefined has increased 100.00% from its 52-week low

No, the XERS stock does not pay dividends to its shareholders

The target price for XERS stock is $9.65 based on the average of what a group of analyst think XERS stock could be worth at a future date. This is not a prediction by Public.com

How to buy XERS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in XERS stock

    Navigate to the Explore page. Then, type XERS into the search bar. When you see XERS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased XERS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Xeris Biopharma Holdings Stock Earnings

The value each XERS share was expected to gain vs. the value that each XERS share actually gained.

XERS (XERS) reported Q1 2025 earnings per share (EPS) of -$0.06, missing estimates of -$0.04 by 50.00%. In the same quarter last year, XERS's earnings per share (EPS) was -$0.14. XERS is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$0.03.

Buy XERS Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.